BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 1769066)

  • 61. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.
    Thwala LN; Préat V; Csaba NS
    Expert Opin Drug Deliv; 2017 Jan; 14(1):23-36. PubMed ID: 27351299
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Noninvasive routes of proteins and peptides drug delivery.
    Jitendra ; Sharma PK; Bansal S; Banik A
    Indian J Pharm Sci; 2011 Jul; 73(4):367-75. PubMed ID: 22707818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mucosal drug delivery: membranes, methodologies, and applications.
    Song Y; Wang Y; Thakur R; Meidan VM; Michniak B
    Crit Rev Ther Drug Carrier Syst; 2004; 21(3):195-256. PubMed ID: 15248809
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Administration strategies for proteins and peptides.
    Ibraheem D; Elaissari A; Fessi H
    Int J Pharm; 2014 Dec; 477(1-2):578-89. PubMed ID: 25445533
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Absorption enhancers for nasal drug delivery.
    Davis SS; Illum L
    Clin Pharmacokinet; 2003; 42(13):1107-28. PubMed ID: 14531723
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transdermal iontophoresis. Part II: Peptide and protein delivery.
    Pillai O; Nair V; Poduri R; Panchagnula R
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):229-40. PubMed ID: 10389126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of permeation enhancers BL-9 and Brij-78 on absorption of four peptide eyedrops in rabbits.
    Chiou GC; Shen ZF; Li BH
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):201-5. PubMed ID: 1442098
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Absorption enhancers as tools to determine the route of nasal absorption of peptides.
    Donnelly A; Kellaway IW; Taylor G; Gibson M
    J Drug Target; 1998; 5(2):121-7. PubMed ID: 9588868
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nose-to-brain peptide delivery - The potential of nanotechnology.
    Samaridou E; Alonso MJ
    Bioorg Med Chem; 2018 Jun; 26(10):2888-2905. PubMed ID: 29170026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel non-invasive protein and peptide drug delivery approaches.
    Wallis L; Kleynhans E; Toit TD; Gouws C; Steyn D; Steenekamp J; Viljoen J; Hamman J
    Protein Pept Lett; 2014; 21(11):1087-101. PubMed ID: 25106909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel engineered systems for oral, mucosal and transdermal drug delivery.
    Li H; Yu Y; Faraji Dana S; Li B; Lee CY; Kang L
    J Drug Target; 2013 Aug; 21(7):611-29. PubMed ID: 23869879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel delivery technologies for protein and peptide therapeutics.
    Kumar TR; Soppimath K; Nachaegari SK
    Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Carrier Mediated Systemic Delivery of Protein and Peptide Therapeutics.
    Zaman R; Othman I; Chowdhury EH
    Curr Pharm Des; 2016; 22(40):6167-6191. PubMed ID: 27510479
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug metabolism in the nasal mucosa.
    Sarkar MA
    Pharm Res; 1992 Jan; 9(1):1-9. PubMed ID: 1589391
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug delivery via the respiratory tract.
    Byron PR; Patton JS
    J Aerosol Med; 1994; 7(1):49-75. PubMed ID: 10147058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Strategies for enhanced peptide and protein delivery.
    McCrudden MT; Singh TR; Migalska K; Donnelly RF
    Ther Deliv; 2013 May; 4(5):593-614. PubMed ID: 23647277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Peptides: important tools for the treatment of central nervous system disorders.
    Malavolta L; Cabral FR
    Neuropeptides; 2011 Oct; 45(5):309-16. PubMed ID: 21477861
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Lysalbinic acid--a new absorption enhancer for the buccal delivery of peptide drugs].
    Starokadomskiĭ PL; Dubeĭ IIa
    Ukr Biokhim Zh (1999); 2005; 77(6):79-85. PubMed ID: 19618746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.